History of Pneumonia in Timeline

Share: FB Share X Share Reddit Share Reddit Share
Pneumonia

Pneumonia is an inflammatory lung condition mainly affecting the alveoli. Common symptoms include cough (productive or dry), chest pain, fever, and breathing difficulties. The illness's severity varies.

1918: Osler describes pneumonia as "captain of the men of death"

In 1918, Sir William Osler, described pneumonia as the "captain of the men of death", because it had overtaken tuberculosis as one of the leading causes of death at the time.

1938: First description of viral pneumonia

In 1938, Hobart Reimann first described viral pneumonia.

1977: Vaccination against Streptococcus pneumoniae in adults begins

In 1977, vaccination against Streptococcus pneumoniae in adults began, resulting in a similar decline in cases.

1988: Vaccination against Haemophilus influenzae type B begins

In 1988, vaccination of infants against Haemophilus influenzae type B began, leading to a dramatic decline in cases shortly thereafter.

2000: Vaccination against Streptococcus pneumoniae in children begins

In 2000, vaccination against Streptococcus pneumoniae in children began, resulting in a similar decline in cases.

2008: Pneumonia cases in children worldwide

In 2008, pneumonia occurred in approximately 156 million children worldwide, with 151 million cases in the developing world and 5 million in the developed world.

2009: Pneumonia is the 8th leading cause of death in the United States

As of 2009, pneumonia is the 8th leading cause of death in the United States.

2009: First World Pneumonia Day

Due to the relatively low awareness of the disease, 12 November was declared in 2009 as the annual World Pneumonia Day.

January 2010: Population-based surveillance begins

From January 2010 through June 2012, a population-based surveillance for community-acquired pneumonia requiring hospitalization was conducted in five hospitals in Chicago and Nashville. 2259 patients were identified with radiographic evidence of pneumonia and specimens that could be tested for the responsible pathogen.

2010: Pneumonia deaths in children worldwide

In 2010, pneumonia resulted in 1.3 million deaths, or 18% of all deaths in those under five years, of which 95% occurred in the developing world.

2011: Pneumonia most common reason for hospital admission in the U.S.

In 2011, pneumonia was the most common reason for admission to the hospital after an emergency department visit in the U.S. for infants and children.

June 2012: Population-based surveillance concludes

From January 2010 through June 2012, a population-based surveillance for community-acquired pneumonia requiring hospitalization was conducted in five hospitals in Chicago and Nashville. 2259 patients were identified with radiographic evidence of pneumonia and specimens that could be tested for the responsible pathogen.

2012: Estimated costs of treating pneumonia in the United States

In 2012 the estimated aggregate costs of treating pneumonia in the United States were $20 billion; the median cost of a single pneumonia-related hospitalization is over $15,000.

2017: Review recommends corticosteroids for severe community acquired pneumonia

A 2017 review recommended the addition of corticosteroids to standard antibiotic treatment for adults with severe community acquired pneumonia to improve outcomes, reducing death and morbidity.

2019: Guideline recommends against general use of corticosteroids

A 2019 guideline recommended against the general use of corticosteroids unless refractory shock was present.

May 2022: FDA recalls Avanos Medical's feeding tube placement system

In May 2022, the FDA recalled Avanos Medical's feeding tube placement system, the CORTRAK* 2 EAS, due to adverse events reported, including pneumonia, which caused a total of 60 injuries and 23 patient deaths.

2023: Vitamin D benefit in children with pneumonia is unclear

As of 2023, the benefit of Vitamin D in children with pneumonia is of unclear benefit.

October 2024: CDC lowers age for adult pneumococcal vaccination

In October 2024, the CDC lowered the age for adult pneumococcal vaccination from 65 to 50 years old to give more adults the opportunity to protect themselves from pneumococcal disease at the age when risk of infection substantially increases.